Literature DB >> 6714291

Acetylator phenotypes: effect of age.

B Gachályi, A Vas, P Hajós, A Káldor.   

Abstract

The distribution of acetylator phenotypes in a Hungarian population of 253 Caucasian was studied. The patients were divided into two age groups - the elderly over 60 years, and young below that age. The individuals below the age of 60 years contained an equal proportion of the two acetylator phenotypes. The same distribution was observed in the population as a whole. In the elderly subjects the slow acetylator phenotype was predominant. The finding supports the hypothesis that age has an influence on hepatic drug acetylation rate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6714291     DOI: 10.1007/bf00546707

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Hepatic drug acetylation and oxidation: effects of aging in man.

Authors:  F Farah; W Taylor; M D Rawlins; O James
Journal:  Br Med J       Date:  1977-07-16

Review 2.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

Review 3.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

4.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

5.  Polymorphic acetylation of sulphadimidine in normal and uraemic man.

Authors:  T Talseth; K H Landmark
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

7.  Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.

Authors:  H Olsen; J Mørland
Journal:  Br Med J       Date:  1978-11-04
  7 in total
  12 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

3.  Influence of age, sex and body weight on the dapsone acetylation phenotype.

Authors:  P A Philip; S L Gayed; H J Rogers; P Crome
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

4.  Pharmacokinetics of isoniazid: influence of age.

Authors:  M F Kergueris; M Bourin; C Larousse
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Distribution of acetylator phenotype in relation to age and sex in Swedish patients. A retrospective study.

Authors:  O Paulsen; L G Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Ageing and acetylator phenotype as determined by administration of sulphadimidine.

Authors:  A E Pontiroli; A De Pasqua; L Bonisolli; G Pozza
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Ageing and acetylator phenotype.

Authors:  B Gachályi; A Vas; A Káldor
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

9.  Pharmacogenetic differences in the inhibitory effect of cimetidine on the metabolism of antipyrine.

Authors:  B Gachályi; A Vas; K Csillag; B Nagy; F Kocsis; A Káldor
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  N-acetylation phenotyping with sulphadimidine in a Turkish population.

Authors:  A Bozkurt; N E Basci; S Kalan; M Tuncer; S O Kayaalp
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.